Study introduces a novel approach to mapping protein-receptor interactions
One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells.
One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells.